News on HIV/AIDS continually updated from thousands of sources around the net.
2 hrs ago | New Hampshire Public Radio -
Three decades after the start of a global epidemic, roughly 35 million people are living with HIV worldwide, and more than a million in the United States.
Do you support affirmative action?
Should nudity be off-limits on prime-time TV?
6 hrs ago | Gay.com
Twenty-four years ago, Summer was born with HIV. But with advancement in medicine, she knows that she can live a long, full life and have a child who does not enter the world with the virus.
University of Miami pediatrician, Judith L. Schaechter, M.D., gives an HPV vaccination to a 13-year-old girl in her office at the Miller School of Medicine on September 21, 2011 in Miami, Fla.
There is a virus, which is at the center of a raging pandemic. The federal Centers for Disease Control estimates that almost half the population of the U.S. is infected with this virus within a few years of becoming sexually active.
A mother waits with her child at an HIV clinic in Nyagasambu, Rwanda, in February 2008.
Spanish experts believe the vaccine will be therapeutic while UK scientists are incorporating a drug to reactivate dormant viral residues.
Vision Group, in association with Twaweza Initiative and Buzz Events, is seeking to recognise artistes whose compositions advance society.
Gilead Sciences has announced that the FDA has approved the single tablet HIV-1 regimen Complera A for use in certain virologically-suppressed adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen.
Yet challenging infections like HIV, malaria and dengue are striking today. To speed up vaccine testing, scientists at the Emory Vaccine Center have established a goal of creating a "vaccine gene chip."
A new documentary warns AIDS advocates that the global fight for access to low-cost HIV drugs isn't over.
In 1983, the problem was getting the media to pay attention to HIV/AIDS. In 2013, the problem is getting the media to pay attention to HIV/AIDS.
A University of Arkansas researcher and her colleagues have found that secondary conditions and diseases that could become deadly significantly affect how long HIV patients stay in the hospital.
A new battle is looming over access to antiviral medicines in developing countries - this time for treating hepatitis C - more than a decade after a global showdown over the price of AIDS drugs in Africa.
Over the years, I've known some masseurs in New York City. All of them told me that ultra-Orthodox Jewish men, nearly all of them married and the heads of large families, constituted a part of their client base.
Agema, who declined comment as he left the Lansing Center, received a standing ovation from some party members and polite applause from others.